Daniel Yerace
Fortuna: 656 644 $ al 31/05/2026
Fortuna: 656 644 $ al 31/05/2026
Daniel Yerace is the founder of Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc. Mr. Yerace is currently Director & Vice President-Operations at Coeptis Therapeutics Holdings, Inc. since 2022.
Formerly, Mr. Yerace was Senior Director-Global Supply Chain at Kadmon Pharmaceuticals LLC.
Mr. Yerace completed undergraduate and MBA degrees at Waynesburg University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,14 % | 11/02/2026 | 70.531 ( 0,14 % ) | 656 644 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NAERODYNAMICS INC | Fundador | - |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Fundador | - |
| Empresas | Cargo | Fin |
|---|---|---|
| COEPTIS THERAPEUTICS | Director de Operaciones | - |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 5 |
|---|---|
Coeptis Therapeutics, Inc.
Coeptis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies novel therapy products for cancer patients | Health Technology |
Waynesburg College
Waynesburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kadmon Pharmaceuticals LLC
Kadmon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Coeptis Pharmaceuticals, Inc.
Coeptis Pharmaceuticals, Inc. BiotechnologyHealth Technology Manufactures biopharmaceutical products | Health Technology |
Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.